Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, which will focus on developing personalized software ...
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current ...
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO, ...
THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...
The Company's lead product candidate, HCW9302, was developed using the Company's legacy TOBI™ (Tissue factOr-Based fusIon) ...
Stockhead on MSN6d
Resources Top 5: Gold discovery sees Kalgoorlie Gold Mining take the spoils with +250pc gainKalgoorlie Gold Mining has made a significant discovery at the Lighthorse target after drilling returned results of up to 17m ...
Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT ...
A new technical paper titled “Exploring Uncore Frequency Scaling for Heterogeneous Computing” was published by researchers at ...
Analysts at TD Cowen started coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating ...
Empowering sustainable supply With geopolitical uncertainties and raw material shortages posing significant challenges, digital product identity ... in the discovery phase, exploring how much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback